FindTrial
Sign In

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00339118
Enrollment
Unknown
Registered
2006-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2006-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhabdomyosarcoma

Brief summary

The purpose of the study is achieve standardization treatment of low and intermediate risk rhabdomyosarcoma patients, with an attempt to improve treatment results in high and very high risk patients by the addition of doxorubicin as induction treatment and at the maintenance phase.

Interventions

DRUGdoxorubicin, cytoxan

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 21 Years
Healthy volunteers
No

Inclusion criteria

* child * non metastatic rhabdomyosarcoma * adequate heart, kidney, liver function

Exclusion criteria

* age over 21 years, under 6 months * metastatic disease * heart, kidney, liver disease

Design outcomes

Primary

MeasureTime frame
event free survival—
overall survival—

Contacts

Primary ContactIris Kventsel, MD
iris.kventsel@sheba.health.gov.il97235303037

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026